Images List Premium Download Classic

Cardiovascular

Cardiovascular-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Novel 5-aminotetrahydroquinoline-2-carboxylic acids and their use
Bayer Pharma Aktiengesellschaft
September 14, 2017 - N°20170260139

The present application relates to novel 5-amino-5,6,7,8-tetrahydroquinoline-2-carboxylic acids, to processes for their preparation, to their use for the treatment and/or prevention of diseases, and to their use for producing medicaments for the treatment and/or prevention of diseases, especially for the treatment and/or prevention of cardiovascular and cardiopulmonary disorders.
Wireless tissue electrostimulation
Cardiac Pacemakers, Inc.
September 14, 2017 - N°20170259070

A wireless electrostimulation system can comprise a wireless energy transmission source, and an implantable cardiovascular wireless electrostimulation node. A receiver circuit comprising an inductive antenna can be configured to capture magnetic energy to generate a tissue electrostimulation. A tissue electrostimulation circuit, coupled to the receiver circuit, can be configured to deliver energy captured by the receiver circuit as a tissue ...
Methods and compositions relating to exosomes
Children's Medical Center Corporation
September 14, 2017 - N°20170258840

The disclosure provides compositions comprising exosome subpopulations, and methods of their use in subjects having certain disorders including lung disorders, cardiovascular disorders, renal disorders and ischemic neural disorders. The disclosure provides compositions comprising exosomes and methods of use thereof in the treatment and/or prevention of various diseases or disorders. 25 accordingly, one aspect of the disclosure provides an isolated exosome. ...
Cardiovascular Patent Pack
Download 516+ patent application PDFs
Cardiovascular Patent Applications
Download 516+ Cardiovascular-related PDFs
For professional research & prior art discovery
inventor
  • 516+ full patent PDF documents of Cardiovascular-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
Amarin Pharmaceuticals Ireland Limited
September 14, 2017 - N°20170258754

In various embodiments, the present invention provides methods of reducing the risk of a cardiovascular event in a subject on statin therapy and, in particular, a method of reducing the risk of a cardiovascular event in a subject on statin therapy having a fasting baseline triglyceride level of about 135 mg/dl to about 500 mg/dl, and administering to the subject ...
Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
Amarin Pharmaceuticals Ireland Limited
September 14, 2017 - N°20170258753

In various embodiments, the present invention provides methods of reducing the risk of a cardiovascular event in a subject on statin therapy and, in particular, a method of reducing the risk of a cardiovascular event in a subject on statin therapy having a fasting baseline triglyceride level of about 135 mg/dl to about 500 mg/dl, and administering to the subject ...
Treatment and prevention of cardiovascular disease and thrombosis
The Cleveland Clinic Foundation
September 14, 2017 - N°20170258740

Provided herein are compositions for the treatment and/or prevention of cardiovascular disease (cvd), and methods of application and use thereof. In particular, the present invention provides treatment and/or prevention of cardiovascular disease with compounds that inhibit the production of tma in the gut, such as 3,3-dimethyl-1-butanol (dmb) or other compounds represented by formula i or as shown ...
Cardiovascular Patent Pack
Download 516+ patent application PDFs
Cardiovascular Patent Applications
Download 516+ Cardiovascular-related PDFs
For professional research & prior art discovery
inventor
  • 516+ full patent PDF documents of Cardiovascular-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Methods for treating patients with hyperlipidemia by administering a pcsk9 inhibitor in combination with an ...
Regeneron Pharmaceuticals, Inc.
September 07, 2017 - N°20170253666

The present invention provides methods for treating patients suffering from hypercholesterolemia, wherein the patient is non-responsive to, inadequately controlled by, or intolerant to treatment with a standard lipid modifying therapy. The methods of the invention provide for lowering at least one lipid parameter in the patient by administering a therapeutically effective amount of an antibody or antigen-binding fragment thereof that ...
Extended antegrade epicardial coronary infusion of adeno-associated viral vectors for gene therapy
Celladon Corporation
September 07, 2017 - N°20170252462

The present invention relates to therapies for the treatment of cardiovascular diseases, particularly the delivery of therapeutic agents to heart tissue by direct infusion into the coronary circulation. A preferred embodiment of the invention is a method of treating or preventing a cardiovascular disease by transfecting cardiac cells of a large mammal, the method comprising, identifying an mammal in need ...
Liraglutide in cardiovascular conditions
Novo Nordisk A/s
September 07, 2017 - N°20170252408

The present invention relates to the glp-1 receptor agonist liraglutide for use in medicine.
Beverages for enhancing sexual performance
Hydro One Llc
September 07, 2017 - N°20170252388

Described herein are beverages that can enhance sexual performance in both men and women. For example, the beverages are useful in promoting endurance and stamina and in increasing sexual desire as well as blood flow to the genital region. Components of the beverages are also associated with a reduced risk of cardiovascular disease in subjects who consume the beverages. The ...
Probiotic bifidobacterium adolescentis strains
Chr. Hansen A/s
September 07, 2017 - N°20170252382

The present invention relates to novel isolated strains of bifidobacterium adolescentis which are capable of i) increasing the trans-epithelial electrical resistance (ter) of a caco-2 cell monolayer after 10 h treatment to more than 120% of ter at treatment start, ii) inducing secretion of >200 pg/ml of il-10, and/or iii) inducing an il-10:il-12 ratio>1 when co-incubated ...
Delivery catheter and catheter arrangement
Biotronik Ag
September 07, 2017 - N°20170252158

A delivery catheter for implanting a self-expanding implant such as a cardiovascular implant. An outer catheter shaft is formed as an implant capsule for encasing the implant during delivery. A flexible distal support element having a substantially truncated cone-shaped portion, which tapers in the proximal direction, is attached, directly proximally of the implant, in a fixed position to a first, ...
Wearable electrocardiography and physiology monitoring ensemble
Bardy Diagnostics, Inc.
September 07, 2017 - N°20170251946

A wearable electrocardiography monitoring ensemble is provided, which includes a garment made of a compressible and elastomeric material. The garment is wearable about an upper region of the torso and further includes an internal structure forming a compressive bias circumferential to the torso. The ensemble also includes an electrode assembly provided on an inside surface of the garment on an ...
Cardiovascular Patent Pack
Download 516+ patent application PDFs
Cardiovascular Patent Applications
Download 516+ Cardiovascular-related PDFs
For professional research & prior art discovery
inventor
  • 516+ full patent PDF documents of Cardiovascular-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Diagnostic method for disorders using copeptin
B.r.a.h.m.s Gmbh
August 24, 2017 - N°20170242037

Disclosed herein is the use of copeptin as a diagnostic marker for the determination of the release of vasopressin, especially in connection with disorders associated with non-physiological alterations of vasopressin release from the neurohypophysis, especially for detection and early detection, diagnosing and monitoring of the course of cardiovascular diseases, renal and pulmonary diseases as well as shock, including septic shock, ...
Human pluripotent stem cell derived endocardial endothelium
University Of Washington
August 24, 2017 - N°20170240861

Provided herein are methods that enable the polarization of hpsc mesoderm such that closely related yet distinct cardiovascular populations can be generated efficiently without the need of post-facto enrichment.
Omega-3 fatty acid ester compositions
Sancilio & Company, Inc.
August 24, 2017 - N°20170240843

Compositions including at least one omega-3 fatty acid ester and at least one surface active agent are provided; wherein the compositions form micelles when in contact with an aqueous medium. Also provided is a method of administering to a subject such a composition, wherein the at least one omega-3 fatty acid ester forms micelles when in contact with an aqueous ...
Amino-substituted annulated pyrimidines and use thereof
Bayer Pharma Aktiengesellschaft
August 24, 2017 - N°20170240566

The present application relates to novel amino-substituted fused pyrimidines, to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.
Soluble epoxide hydrolase inhibitors and uses thereof
X-chem, Inc.
August 24, 2017 - N°20170240526

The present invention features compounds having soluble epoxide hydrolase inhibitory activity. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing various medical conditions, such as cardiovascular diseases, respiratory diseases, inflammation, and diabetes.
Methods and systems for lowering blood pressure through reduction of ventricle filling
Backbeat Medical, Inc.
August 24, 2017 - N°20170239481

Methods and devices for reducing ventricle filling volume are disclosed. In some embodiments, an electrical stimulator may be used to stimulate a patient's heart to reduce ventricle filling volume or even blood pressure. When the heart is stimulated in a consistent way to reduce blood pressure, the cardiovascular system may over time adapt to the stimulation and revert back to ...
Small-molecule ut-a-selective urea transport inihibitors
The Regents Of The University Of California
August 24, 2017 - N°20170239235

Provided herein are compounds that are urea transporter-a inhibitors that are useful for producing a strong diuretic response and may be used for treating refractory edema associated with cardiovascular, renal, and metabolic diseases, disorders, and conditions.
Toxic aldehyde related diseases and treatment
Aldeyra Therapeutics, Inc.
August 24, 2017 - N°20170239196

The present invention provides for the treatment, prevention, and/or reduction of a risk of a disease, disorder, or condition in which aldehyde toxicity is implicated in the pathogenesis, including ocular disorders, skin disorders, conditions associated with injurious effects from blister agents, and autoimmune, inflammatory, neurological and cardiovascular diseases by the use of a primary amine to scavenge toxic aldehydes, ...
Loading